Won Keun Oh Selected Research

Non-Receptor Type 1 Protein Tyrosine Phosphatase

7/2014	Oleanane triterpenes as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Camellia japonica.
11/2012	New prenylated isoflavonoids as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Erythrina addisoniae.
2/2007	Protein tyrosine phosphatase 1B inhibitory activity of amentoflavone and its cellular effect on tyrosine phosphorylation of insulin receptors.
8/2006	PTP1B inhibitory activity of kaurane diterpenes isolated from Siegesbeckia glabrescens.
8/2006	Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans.
8/2006	Inhibition of protein tyrosine phosphatase 1B by prenylated isoflavonoids isolated from the stem bark of Erythrina addisoniae.
6/2006	Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum.
2/2006	Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata.
9/2005	PTP1B inhibitory effect of abietane diterpenes isolated from Salvia miltiorrhiza.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won Keun Oh Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 07/2003
15	Obesity 03/2021 - 02/2006
10	Human Influenza (Influenza) 01/2021 - 11/2010
10	Type 2 Diabetes Mellitus (MODY) 11/2018 - 09/2005
9	Breast Neoplasms (Breast Cancer) 08/2016 - 08/2009
5	Inflammation (Inflammations) 01/2022 - 12/2015
4	Infections 09/2020 - 12/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 07/2010
3	Hypertension (High Blood Pressure) 03/2021 - 02/2014
3	Neuroinflammatory Diseases 09/2019 - 12/2016
3	Atherosclerosis 04/2014 - 09/2009
3	Hypoxia (Hypoxemia) 10/2012 - 01/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 07/2010
2	Arthritis (Polyarthritis) 02/2020 - 11/2018
2	Rheumatoid Arthritis 02/2020 - 11/2018
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2016
2	Muscular Atrophy (Muscle Atrophy) 04/2018 - 02/2018
2	Atrophy 04/2018 - 02/2018
2	Parkinson Disease (Parkinson's Disease) 07/2015 - 03/2013
2	Hyperplasia 02/2013 - 10/2010
2	Communicable Diseases (Infectious Diseases) 09/2010 - 05/2010
1	COVID-19 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Uveitis 01/2022
1	Respiratory Syncytial Virus Infections 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Diabetes Mellitus 03/2021
1	Chronic Disease (Chronic Diseases) 03/2021
1	Virus Diseases (Viral Diseases) 09/2020
1	Common Cold 09/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Necrosis 11/2018
1	Pain (Aches) 10/2018
1	Cognitive Dysfunction 10/2018
1	Mental Disorders (Mental Disorder) 10/2018

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 09/2005
9	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 07/2014 - 09/2005
7	Neuraminidase (Sialidase)IBA 07/2020 - 05/2010
7	Sirtuin 1IBA 11/2015 - 07/2010
6	Proteins (Proteins, Gene)FDA Link 09/2020 - 11/2006
6	amurensin GIBA 11/2015 - 11/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2012 - 12/2009
4	Tamoxifen FDA LinkGeneric 08/2016 - 12/2009
3	LipopolysaccharidesIBA 01/2022 - 12/2016
3	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2019
3	Therapeutic UsesIBA 01/2022 - 11/2018
3	Biological ProductsIBA 09/2019 - 12/2015
3	LipidsIBA 01/2019 - 08/2009
3	UbiquitinIBA 04/2018 - 11/2015
3	Ligases (Synthetase)IBA 04/2018 - 11/2015
3	CholesterolIBA 12/2015 - 10/2006
3	Oseltamivir (Tamiflu)FDA Link 06/2012 - 11/2010
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2010 - 09/2006
2	PhytochemicalsIBA 03/2021 - 12/2016
2	Phosphotransferases (Kinase)IBA 12/2020 - 02/2014
2	LigandsIBA 11/2018 - 12/2015
2	FlavonoidsIBA 05/2018 - 11/2010
2	conessineIBA 04/2018 - 02/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2018 - 02/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2015 - 01/2010
2	Antineoplastic Agents (Antineoplastics)IBA 11/2015 - 11/2010
2	nectandrin-BIBA 04/2014 - 02/2013
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2014 - 12/2012
2	ginsenoside RdIBA 02/2013 - 01/2010
2	AMP-Activated Protein KinasesIBA 09/2012 - 07/2010
2	ResveratrolIBA 10/2010 - 09/2010
2	Insulin (Novolin)FDA Link 05/2010 - 09/2005
2	Tyrosine (L-Tyrosine)FDA Link 12/2009 - 11/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2009 - 10/2006
2	NF-kappa B (NF-kB)IBA 11/2006 - 08/2005
1	Disinfectants (Biocides)IBA 01/2022
1	VaccinesIBA 01/2022
1	InterleukinsIBA 01/2022
1	piperineIBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	polyhexamethyleneguanidineIBA 01/2022
1	cristacarpinIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	SenotherapeuticsIBA 01/2022
1	Cyclic PeptidesIBA 01/2021
1	Furocoumarins (Furanocoumarins)IBA 09/2020
1	Hemagglutinins (Hemagglutinin)IBA 09/2020
1	kumi-kyokatsu-toIBA 09/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2018
1	2,4,6-trihydroxyacetophenoneIBA 11/2018
1	Leukemia Inhibitory FactorIBA 11/2018

Therapy/Procedure

8	Therapeutics 11/2018 - 08/2005
3	Drug Therapy (Chemotherapy) 11/2010 - 01/2010
2	Oral Administration 09/2012 - 10/2010
1	Humidifiers 01/2022
1	Traditional Medicine (Folk Remedies) 03/2021